08-018
|
F
|
70
|
IPAH
|
EUR
|
FBLN2
|
58
|
14
|
III
|
No
|
HTN, kidney congenital anomaly, Paget’s disease
|
17-035
|
F
|
41
|
APAH (MCTD)
|
EAS
|
FBLN2
|
43
|
16
|
III
|
No
| |
12-207*
|
F
|
44
|
IPAH
|
EUR
|
FBLN2
|
NA
|
NA
|
NA
|
No
|
HTN, hypothyroidism
|
23-001
|
M
|
66
|
IPAH
|
EUR
|
FBLN2
|
68
|
10
|
III
|
No
|
HTN, OLD (smoker)
|
29-031
|
F
|
57
|
IPAH
|
EUR
|
FBLN2
|
84
|
15
|
NA
|
No
|
HTN, mitral valve disease, hypothyroidism, OA, COPD
|
34-005*
|
M
|
69
|
IPAH
|
EUR
|
FBLN2
|
43
|
14
|
NA
|
No
|
HTN, CAD
|
W000210
|
F
|
52
|
IPAH
|
EUR
|
FBLN2
|
75
|
11
|
II
|
No
|
Hyposplenism
|
Mean ± SD
|
2.5:1
|
53 ± 11
| | | |
62 ± 17
|
13 ± 2
| | | |
W000073*
|
F
|
40
|
IPAH
|
AFR
|
PDGFD
|
73
|
NA
|
III
|
No
|
PFO, bilateral chronic subdural hematoma, hypothyroidism
|
JM930
|
F
|
2
|
IPAH
|
EUR
|
PDGFD
|
39
|
NA
|
NA
|
No
|
Bronchopulmonary dysplasia
|
E012465
|
F
|
55
|
IPAH
|
EUR
|
PDGFD
|
52
|
7
|
III
|
No
|
Hypothyroidism, IBS, major depression
|
E014342*
|
F
|
40
|
IPAH
|
EUR
|
PDGFD
|
57
|
7
|
III
|
No
|
Emphysema
|
E014400
|
F
|
43
|
IPAH
|
EUR
|
PDGFD
|
57
|
4
|
III
|
No
|
Obesity, T2DM
|
E000844
|
F
|
39
|
IPAH
|
EUR
|
PDGFD
|
51
|
9
|
III
|
No
|
GERD, asthma, bicornate uterus
|
13-037
|
M
|
43
|
DTOX
|
EUR
|
PDGFD
|
47
|
7
|
II
|
No
|
None
|
23-025*
|
F
|
41
|
IPAH
|
EUR
|
PDGFD
|
64
|
NA
|
III
|
No
|
Hypothyroidism
|
E000820
|
F
|
73
|
IPAH
|
EUR
|
PDGFD
|
48
|
9
|
II
|
No
|
Fatty liver, hypothyroidism, ductal carcinoma, gallstones, superior vena cava and azygos vein thrombosis related to port-a-cath
|
E010173
|
F
|
74
|
IPAH
|
EUR
|
PDGFD
|
32
|
9
|
III
|
No
|
MPVD, PVD, obesity, T2DM, HTN, chronic renal impairment, hypothyroidism, OA, hypouricemia, major depression
|
Mean ± SD
|
9:1**
|
50 ± 14
| | | |
53 ± 12
|
11 ± 10
| | | |